Renovacor, Inc.

Chardan NexTech Acquisition 2 Corp. (Nasdaq: CHAQ), a blank-check company sponsored by Chardan Capital Markets, completed its initial public offering in 2021 targeting the healthcare and life sciences sector. In October 2021, Renovacor, Inc. filed an S-1 registration statement in connection with the proposed business combination with CHAQ, reflecting the de-SPAC process by which Renovacor — a clinical-stage gene therapy company focused on inherited cardiovascular diseases — sought to access public markets. The filing, bearing accession number 0001193125-21-300164, marked a key procedural step in the transaction review process. Sign up at SpacDesk for full filing history, status updates, and sponsor analytics on CHAQ and hundreds of other SPAC transactions.